Immunoconjugates in drug delivery systems
- PMID: 2131008
Immunoconjugates in drug delivery systems
Similar articles
-
[Application of monoclonal antibody for drug delivery system--missile therapy for cancer].Nihon Rinsho. 1998 Mar;56(3):638-43. Nihon Rinsho. 1998. PMID: 9549349 Review. Japanese.
-
Drug-immunoglobulin conjugates as targeted therapeutic systems.Targeted Diagn Ther. 1990;3:141-87. Targeted Diagn Ther. 1990. PMID: 2131009 Review. No abstract available.
-
Antibody conjugates and therapeutic strategies.Mol Interv. 2005 Dec;5(6):368-80. doi: 10.1124/mi.5.6.9. Mol Interv. 2005. PMID: 16394252 Review.
-
[Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].Nihon Rinsho. 1989 Jun;47(6):1391-5. Nihon Rinsho. 1989. PMID: 2475654 Japanese. No abstract available.
-
Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.J Drug Target. 2008 Aug;16(7):601-4. doi: 10.1080/10611860802228954. J Drug Target. 2008. PMID: 18686131
Cited by
-
Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds.Antimicrob Agents Chemother. 1993 Sep;37(9):1890-5. doi: 10.1128/AAC.37.9.1890. Antimicrob Agents Chemother. 1993. PMID: 8239602 Free PMC article.
-
An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models.Cancer Immunol Immunother. 1995 May;40(5):322-8. doi: 10.1007/BF01519633. Cancer Immunol Immunother. 1995. PMID: 7600565 Free PMC article.